Stated history of endometrial cancer. Endometrial adenocarcinoma, endometrioid type, FIGO grade I, with focal squamous differentiated. PELVIS:UTERUS, ADNEXA: The uterus is markedly enlarged, measuring 18.3 x 10.6 cm and lobular in contour containing numerous well-defined T2 hypointense masses demonstrating gradual heterogeneous postcontrast enhancement compatible with multiple fibroids with the largest in the fundus measuring 9.6 x 6.9 cm in the sagittal plane.The endometrial cavity is distended with T2 weighted hypointense and T1 weighted mildly hyperintense nonenhancing blood product extending into a distended cervix and the proximal vaginal canal. This includes several submucosal fibroids.In the right fundus of the uterus there is a broad-based mucosal based lesion measuring 5.2 x 2.0 cm demonstrating mild postcontrast enhancement compatible with patient's stated history of endometrial carcinoma. Within the limitations of a heterogeneously enhancing myometrium there appears to be minimal tumoral extension involving less than 50% of the myometrial thickness. The parametrial soft tissues are unremarkable.BLADDER: No significant abnormality noted.LYMPH NODES: 2.9 x 2.3 heterogeneously enhancing lesion in the right inguinal region suspicious for a pathologic lymph node.BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: Partially imaged 5.4 cm fat-containing umbilical hernia.OTHER: Multilevel degenerative disc disease.
1.9.6 x 6.9 cm endometrial mass with minimal tumoral extension appearing to involve less than 50 % of the myometrial thickness. 2.2.9 x 2.3 cm suspicious right inguinal lymphadenopathy. No enlarged pelvic lymphadenopathy delineated.